Results 321 to 330 of about 3,018,484 (379)
Off-label use of teriparatide for the treatment of a vertebral burst fracture in a young patient: A case report and literature review. [PDF]
Villa T +4 more
europepmc +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Off-label use of commercially available topical sirolimus for keratosis pilaris rubra faciei. [PDF]
Snow KP, Ong SK, Siegfried E.
europepmc +1 more source
Facial hair enhancement with minoxidil-an off-label use. [PDF]
Shokravi A, Zargham H.
europepmc +1 more source
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]
Zhao B +28 more
europepmc +1 more source
Prescribing Patterns and Off-Label Use of Gabapentinoid Agents at Dhulikhel Hospital, Nepal: A Cross-Sectional Study. [PDF]
Adhikari S +3 more
europepmc +1 more source

